By establishing a tissue-specific SPOP-F133V overexpressing GEM model, Blattner and colleagues reported that SPOP mutation promotes prostate tumorigenesis through coordinate regulation of PI3K/mTOR and AR signaling (101). This evidence concerns the gene SPOP and medical procedure.